5-Fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 97%, 100mg

(2-(Methoxycarbonyl)-4-(trifluoromethyl)phenyl)boronic acid, 95.0%, 500mg

3-Chloro-7H-pyrrolo[2,3-c]pyridazine, 95.0%, 250mg

5-Phenylpent-4-yn-1-ol, 98%, 250mg

4-Bromo-5-nitropyridin-2-amine, 95.0%, 1g

2-Chloro-6-piperidin-1-yl-pyrazine, 97.0%, 1g

Tetramethylsilane, min. 99.9%, for NMR spectroscopy, 100 ml, glass packaging

Needles Point type 3 for GASTIGHT® syringes series 1700, Gesch. for, >= 250 μl, 6 pieces

2-Amino-N-phenylacetamide hydrochloride, 95.0%, 2.5g

Test tube, 25 ml, 100 Piece(s)

Cyclohexylboronic acid, 97.0%, 100g

(1-Isopropyl-3-oxo-piperazin-2-yl)-acetic acid, 95.0%, 1g

Methyl 5,6-dibromopicolinate, 95.0%, 250mg